Review Article

Cognitive Outcomes following Transcatheter Aortic Valve Implantation: A Systematic Review

Table 1

Summary of studies measuring global cognition after TAVI using the MMSE.

StudyType of TAVIBaselineAfter procedure1-month F/U3-month F/U

Orvin et al., 2014 [8]36TF (MCV) = 31
TA (MCV) = 5
25.9 ± 3.327.6 ± 2.4
< 0.001

Ghanem et al., 2013 [6]111TF (MCV) = 95
TF (ES) = 16
25.4 ± 3.425.4 ± 3.3a
25.1 ± 3.8b
= 0.58

Kahlert et al., 2012 [9]83Overall 27.9
(27.5–28.3)
27.7
(27.3–28.2)
= 0.521
28.3
(28.0–28.7)
< 0.001
TF (MCV) = 32 28.0
(27.5–28.5)
27.7
(27.3–28.2)
= 0.488
28.4
(27.9–28.9)
= 0.083
TF (ES) = 26 27.3
(26.1–28.6)
27.6
(26.4–28.7)
= 0.400
28.1
(27.0–29.1)
= 0.003
TA (ES) = 25 28.3
(27.8–28.8)
28.0
(27.4–28.5)
= 0.256
28.6
(28.1–29.0)
= 0.096

Knipp et al., 2013 [10]27TA (ES) = 27−0.72 ± 1.42c
> 0.05
0.95 ± 1.20c
< 0.05

Rodés-Cabau et al., 2011 [11]60TF (ES) = 29
TA (ES) = 31
28
(17–30)
28
(16–30)
= 0.14

Kahlert et al., 2010 [12]32TF (MCV) = 1028.9
(28.2–29.6)
28.0
(27.0–29.0)
> 0.05
28.9
(28.0–29.0)
> 0.05
TF (ES) = 2228.1
(26.7–29.5)
28.3
(27.1–29.6)
> 0.05
28.1
(26.7–29.7)
> 0.05

= number, TAVI = transcatheter aortic valve implantation, MMSE = mini-mental status examination, TF = transfemoral, TA = transapical or transaxillary, ES = Edwards-SAPIEN, MCV = Medtronic CoreValve, and F/U = follow-up.
All studies were observational prospective cohort study. values are for MMSE scores from the specified time-point compared to baseline unless otherwise stated. Normal score for MMSE is 24 or above.
aSubgroup with no risk of cognitive decline.
bSubgroup with risk of cognitive decline.
cChange in -score after procedure to follow-up.